JUBILANT LIFE SCIENCES LTD.

NSE : JUBILANTBSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE927.2038.7 (+4.36 %)
PREV CLOSE ( ) 888.50
OPEN PRICE ( ) 914.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29358
TODAY'S LOW / HIGH ( )881.95 931.15
52 WK LOW / HIGH ( )230 1012.85
NSE927.4539.1 (+4.4 %)
PREV CLOSE( ) 888.35
OPEN PRICE ( ) 895.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 927.45 (2401)
VOLUME 533412
TODAY'S LOW / HIGH( ) 882.30 931.75
52 WK LOW / HIGH ( )234.35 1010
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-06 1978
Management Info
Shyam S Bhartia - Chairman Hari S Bhartia - Managing Director
Registered Office

Address Bhartiagram ,Jyotiba Phoolay Nagar, ,
Gajraula,
Uttar Pradesh-244223

Phone +91-5924-252351-60

Email invstors@jubl.com

Website www.jubl.com

Registrars Details
Alankit Assignments Ltd.
205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX
NEWS
18Jan Announcement under Regulation 30 (LOD
Outcome of the Restructuring Committee Meeting held on January 18, 2021..
14Jan Jubilant Life Sciences raises Rs 95 cr
Jubilant Life Sciences has raised Rs 95 crore through Non-convertible De..
11Jan Announcement under Regulation 30 (LOD
Outcome of the Restructuring Committee Meeting held on January 8, 2021 -..
24Dec Intimation Under Regulation 30 Of The
We wish to inform you that the Hon''ble National Company Law Tribunal, A..
26Nov Jubilant Life Sciences issues CPs of R
Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 90 crore..
Financials
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit626.33211.4
Gross Profit 752.3 2988.4
Operating Profit 1320.35441.4
Net Sales 7607.531399
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 3754.85 (4.43%)
M.Cap (Rs. in Cr)9387.13
Procter&Gamble Healt (BSE)
 7178.50 (1.21%)
M.Cap (Rs. in Cr)11915.87
NGL Fine-Chem (BSE)
 1244.70 (3.17%)
M.Cap (Rs. in Cr)768.98
IOL Chem & Pharma (BSE)
 709.95 (3.55%)
M.Cap (Rs. in Cr)4167.80
Orchid Pharma (BSE)
 302.90 (4.99%)
M.Cap (Rs. in Cr)1236.33
Shareholding Pattern
PROMOTERS 50.68%
NON-INSTITUTION 22.57%
MUTUAL FUNDS/UTI 0.57%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.